Articles
| Open Access | UNCOVERING DRUG RESISTANCE PATTERNS: SINGLE-DOSE NEVIRAPINE EXPOSURE AND EMERGENT MUTATIONS IN HIV-1 INFECTED PREGNANT WOMEN IN SOUTH INDIA
Soumya Narayanan , Tuberculosis Research Centre (Icmr), Chennai, IndiaAbstract
The emergence of drug-resistant mutations in HIV-1 infected pregnant women in South India following single-dose nevirapine exposure presents a critical challenge in the prevention of mother-to-child transmission of HIV. This study investigates the prevalence and patterns of drug resistance mutations in this vulnerable population. By analyzing viral sequences from a cohort of HIV-1 infected pregnant women who received single-dose nevirapine, we elucidate the dynamics of resistance development and its implications for antiretroviral therapy. Our findings underscore the importance of effective strategies to mitigate drug resistance in this context and advance the goal of eliminating vertical HIV transmission.
Keywords
Drug resistance mutations, Single-dose nevirapine, Pregnant women
References
UNAIDS WHO. HIV/AIDS Epidemic update. Epidemiological fact sheet on HIV/AIDS, India- WHO/UNAIDS. 2008 update131. 2007. Available at: http://www.unaids.org/en/ Knowledge Centre/HIV Data/Epi Update/Epi Upd Archive/2007 /default.asp, accessed on December 22, 2008.
NACO. Guidelines for HIV care and treatment in infants and children. 2006.Available at: http://www.nacoonline.org/Quick_ Links/Publication/Treatment_Care__Support/Operational__ Technical_guidelines_and_policies/Guidelines_for_HIV_Care_and_Treatment/, accessed o December 22, 2008.
Giaquinto C, Rampon O, de Rossi A. Antiretroviral therapy for prevention of mother to child transmission. Clin Drug Invest 2006; 26 : 611-27.
Use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Rapid Advice, WHO guidelines. Geneva: WHO; 2009.
Jourdain G, Ngo-Giang-Huong N, Le Coeur S, Bowonwatanuwong C, Kantipong P, Leechanachai P, et al. Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy. N Engl J Med 2004; 351 : 229-40.
ViroSeq HIV-1 Genotyping System v2.0, User manual USA: Celera Diagnostics; 2004.
Johnson VA, Brun-Vezinet F, Clotet B, Gunthard HF, Kuritzkes DR, Pillay D, et al. Update of the drug resistance mutations in HIV-1. Top HIV Med 2008; 16 : 138-45.